Infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: HCG + decapeptyl - in group A, a dose of 1500 units of HCG is prescribed 12 hours after the trigger with (decapeptyl) triptorelin sc. Intervention 2: Control group:
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: Selection of women with PCOS based on ESHRE ASRM Rotterdam criteria Stimulation with GnRH antagonist protocol Age 20-38 years E2 concentration > 2500 international units on the trigger day Body mass index > 18 and < 30 Having an indication for IVF or ICSI Willingness to participate in the study
Exclusion criteria
Exclusion criteria: severe cause of male infertility Uterine anomalies Severe endometriosis metabolic disease (e.g. metabolic syndrome) Age above 38 and below 20 years Patients with hypogonadism, hypogonadotropism Patients with underlying diseases such as thyroid, hyperprolactinemia, Cushing's syndrome, ovarian and adrenal tumors, diabetes, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of mature oocytes. Timepoint: 34-36 hours after decapeptil injection. Method of measurement: Trans vaginal ultrasound.;Number of retrieved oocytes. Timepoint: 34-36 hours after decapeptil injection. Method of measurement: Trans vaginal ultrasound.;The number of blastocysts. Timepoint: Two weeks after administration of Decapeptil. Method of measurement: Abdominal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive pregnancy test. Timepoint: 4 weeks after IVF. Method of measurement: Beta HCG test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Atena Khayambashi
Esfahan University of Medical Sciences
Outcome results
None listed